Regdanvimab (CT-P59) is a fully human monoclonal antibody that targets the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein, preventing viral entry by blocking ACE2 interaction. It is widely used in COVID-19 research, including viral neutralization, variant efficacy assessment, and therapeutic antibody development.
Regdanvimab (CT-P59) is a fully human monoclonal antibody that targets the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein, preventing viral entry by blocking ACE2 interaction. It is widely used in COVID-19 research, including viral neutralization, variant efficacy assessment, and therapeutic antibody development.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: